.Merck trumps profits requirements, rears purchases outlook on tough requirement for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Estimates as Keytruda Purchases Rise BloombergMerck Stock: Pharma Giant Posts Strong Results, Yet Overview Tumbles Short Entrepreneur's Service DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats income as well as sales desires amid Keytruda advantage, but provides combined full-year expectation MarketWatch.